However, none of these three patients with cardiovascular disease were included in the TMT Labeling proteomic studies (Table S9), and cardiovascular disease did not impact cadherin-13 levels in plasma (Figure S1A). The gene discussed is CDH13; the disease is cardiovascular disorder.